0       0


MN3-27: Revolutionizing Cellular Therapy (AABB/NMDP Joint Session)


Oct 21, 2019 2:00pm ‐ Oct 21, 2019 3:30pm

Description

Businesses in this rapidly changing field must adapt to advancing technology, drug development and associated regulation and maximize existing synergies within the cellular therapy environment for the benefit of donors and patients.

Learning Objectives:

  • Establish a BioBank with the capability to collect and bank a variety of donor cell types to provide an expedited pathway to transplant and improve outcomes for patients.
  • Create a comprehensive quality system approach to relieve the burden on collection centers and cellular therapy labs, and support the collection of high quality products.
  • Establish regulations that allow novel therapies to be created from banked products.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content